Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
8256
|
| pubmed:dateCreated |
1982-2-12
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
AIM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Nov
|
| pubmed:issn |
0140-6736
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:day |
21
|
| pubmed:volume |
2
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
1139-42
|
| pubmed:dateRevised |
2011-11-17
|
| pubmed:meshHeading |
pubmed-meshheading:6118580-Antibodies, Bacterial,
pubmed-meshheading:6118580-Bacterial Proteins,
pubmed-meshheading:6118580-Cloning, Molecular,
pubmed-meshheading:6118580-DNA, Recombinant,
pubmed-meshheading:6118580-Escherichia coli,
pubmed-meshheading:6118580-Humans,
pubmed-meshheading:6118580-Insulin
|
| pubmed:year |
1981
|
| pubmed:articleTitle |
Preliminary studies on the immunogenicity and amount of Escherichia coli polypeptides in biosynthetic human insulin produced by recombinant DNA technology.
|
| pubmed:publicationType |
Journal Article
|